Vivos (RDGL) Operating Margin Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Vivos | - | - | -3,105.00 | 882,246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 882,246.00 |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -62,952.00 |
| Mar 31, 2025 | 959,669.00 |
| Sep 30, 2024 | -703,957.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -868,646.00 |
| Sep 30, 2023 | -556,079.00 |
| Jun 30, 2023 | -656,741.00 |
| Mar 31, 2023 | 161,131.00 |
| Sep 30, 2022 | -295,547.00 |
| Sep 30, 2021 | 52,779.00 |
| Sep 30, 2020 | 575,523.00 |
| Mar 31, 2018 | 736,591.00 |
| Mar 31, 2017 | 783,957.00 |
| Sep 30, 2016 | -1.40 Mn |
| Mar 31, 2016 | -1.41 Mn |
| Mar 31, 2015 | 115,500.00 |
| Mar 31, 2014 | 214,576.00 |
| Sep 30, 2013 | 307,091.00 |
| Mar 31, 2013 | -453,231.00 |
| Dec 31, 2012 | -71,423.00 |
| Sep 30, 2012 | -254,935.00 |
| Jun 30, 2012 | -336,638.00 |
| Mar 31, 2012 | -35,939.00 |
| Dec 31, 2011 | -121,498.00 |